Skip to main content

Table 1 Outcome assessments during the RADMIS trial

From: Reducing the rate and duration of Re-ADMISsions among patients with unipolar disorder and bipolar disorder using smartphone-based monitoring and treatment – the RADMIS trials: study protocol for two randomized controlled trials

 

SCAN and background information

Rating scales

Questionnaires

Clinical information

Baseline

x

x

x

x

Randomization to (1) smartphone-based monitoring and treatment (the intervention group) or (2) treatment-as-usual (the control group)

3-month follow-up

 

x

x

x

6-month follow-up

 

x

x

x

  1. SCAN Schedules for Clinical Assessment in Neuropsychiatry interview
  2. Rating scales: Hamilton Depression Rating Scale 17-item (HDRS-17); Young Mania Rating Scale (only for patients with a bipolar disorder diagnosis); Psychosocial functioning test (Functional Assessment Short Test (FAST))
  3. Questionnaires: perceived stress according to Cohen’s Perceived Stress Scale; quality of life according to the WHO Quality of Life-BREF (WHOQOL-BREF); self-rated depressive symptoms according to Beck’s Depressive Inventory (BDI); self-rated depressive symptoms according to the Hamilton Depression Self-rating Scale 6-item (HDRS-6); self-rated manic symptoms according to the Altman Self-rating Scale for Mania (ASRM) (only for patients with a bipolar disorder diagnosis); recovery according to the Recovery Assessment Scale; empowerment according to Rogers’ Empowerment Scale; adherence to medication according to the Medicine Adherence Rating Scale; wellbeing according to the WHO (five) Wellbeing Index; rumination according to the Rumination Response Scale (RRS); worrying according to the Penn State Worry Questionnaire (PSWQ); satisfaction according to the Verona Satisfaction Scale-Affective Disorder (VSS-A). The HDRS-6, the ASRM and the WHO (five) are filled out every month during the study 6-month period
  4. Clinical information: re-admissions and duration of re-admissions (register data); number of affective episodes; number of contacts with clinicians and psychiatric emergency rooms; hospitalizations; medication, etc
Back to article page

Trials

ISSN: 1745-6215